MINNNEAPOLIS (Oct. 21, 2021) – Sofia Fund, the angel investment firm focused exclusively on women-led companies, announces new milestones: two of its portfolio companies have progressed onto their next stages of growth, providing returns for Sofia’s group of investors.
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company engages in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina, has completed an initial public offering. Cognition’s common stock is now listed on The Nasdaq Global Market under the symbol “CGTX.” Sofia Fund made three investments in Pittsburgh-based CGTX, recognizing the strength of the company’s diverse leadership team and its vision to solve an unmet need in the marketplace.
Explorer Surgical Corp., which provides digital and remote case support platforms that connect medical device suppliers with healthcare provider teams inside the operating room, has been acquired by Global Healthcare Exchange (GHX). Explorer Surgical will operate as a wholly owned subsidiary of GHX, a company that automates key business processes and translates evidence-based analytics and data for healthcare. New York-based Explorer Surgical became part of the Sofia Fund portfolio in March 2021.
“Both of these companies demonstrate the demand for health and wellness technology and are examples of well-managed, high-growth businesses run by women,” said Cathy Connett, managing partner of Sofia Fund and an experienced investor in early-stage companies. “These are big wins for these entrepreneurs and the growing community of women investing in other women.”
Sofia Fund was one of the first investment groups to focus exclusively on gender-diverse startups and has brought many women into the asset class of angel investing. It concentrates its investments in the IT, enterprise solutions, technology, and health and wellness sectors.
